table of content
1 Study Coverage
1.1 Poliomyelitis Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Poliomyelitis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 IPV
1.2.3 OPV
1.3 Market by Application
1.3.1 Global Poliomyelitis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Poliomyelitis Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Poliomyelitis Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Poliomyelitis Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Poliomyelitis Vaccines Sales by Region
2.4.1 Global Poliomyelitis Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Poliomyelitis Vaccines by Region (2023-2028)
2.5 Global Poliomyelitis Vaccines Revenue by Region
2.5.1 Global Poliomyelitis Vaccines Revenue by Region (2017-2022)
2.5.2 Global Poliomyelitis Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Poliomyelitis Vaccines Sales by Manufacturers
3.1.1 Global Top Poliomyelitis Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poliomyelitis Vaccines in 2021
3.2 Global Poliomyelitis Vaccines Revenue by Manufacturers
3.2.1 Global Poliomyelitis Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Poliomyelitis Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Poliomyelitis Vaccines Revenue in 2021
3.3 Global Poliomyelitis Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Poliomyelitis Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Poliomyelitis Vaccines Sales by Type
4.1.1 Global Poliomyelitis Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Poliomyelitis Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Poliomyelitis Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Poliomyelitis Vaccines Revenue by Type
4.2.1 Global Poliomyelitis Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Poliomyelitis Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Poliomyelitis Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Poliomyelitis Vaccines Price by Type
4.3.1 Global Poliomyelitis Vaccines Price by Type (2017-2022)
4.3.2 Global Poliomyelitis Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Poliomyelitis Vaccines Sales by Application
5.1.1 Global Poliomyelitis Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Poliomyelitis Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Poliomyelitis Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Poliomyelitis Vaccines Revenue by Application
5.2.1 Global Poliomyelitis Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Poliomyelitis Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Poliomyelitis Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Poliomyelitis Vaccines Price by Application
5.3.1 Global Poliomyelitis Vaccines Price by Application (2017-2022)
5.3.2 Global Poliomyelitis Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Poliomyelitis Vaccines Market Size by Type
6.1.1 North America Poliomyelitis Vaccines Sales by Type (2017-2028)
6.1.2 North America Poliomyelitis Vaccines Revenue by Type (2017-2028)
6.2 North America Poliomyelitis Vaccines Market Size by Application
6.2.1 North America Poliomyelitis Vaccines Sales by Application (2017-2028)
6.2.2 North America Poliomyelitis Vaccines Revenue by Application (2017-2028)
6.3 North America Poliomyelitis Vaccines Market Size by Country
6.3.1 North America Poliomyelitis Vaccines Sales by Country (2017-2028)
6.3.2 North America Poliomyelitis Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Poliomyelitis Vaccines Market Size by Type
7.1.1 Europe Poliomyelitis Vaccines Sales by Type (2017-2028)
7.1.2 Europe Poliomyelitis Vaccines Revenue by Type (2017-2028)
7.2 Europe Poliomyelitis Vaccines Market Size by Application
7.2.1 Europe Poliomyelitis Vaccines Sales by Application (2017-2028)
7.2.2 Europe Poliomyelitis Vaccines Revenue by Application (2017-2028)
7.3 Europe Poliomyelitis Vaccines Market Size by Country
7.3.1 Europe Poliomyelitis Vaccines Sales by Country (2017-2028)
7.3.2 Europe Poliomyelitis Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Poliomyelitis Vaccines Market Size by Type
8.1.1 Asia Pacific Poliomyelitis Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Poliomyelitis Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Poliomyelitis Vaccines Market Size by Application
8.2.1 Asia Pacific Poliomyelitis Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Poliomyelitis Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Poliomyelitis Vaccines Market Size by Region
8.3.1 Asia Pacific Poliomyelitis Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Poliomyelitis Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Poliomyelitis Vaccines Market Size by Type
9.1.1 Latin America Poliomyelitis Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Poliomyelitis Vaccines Revenue by Type (2017-2028)
9.2 Latin America Poliomyelitis Vaccines Market Size by Application
9.2.1 Latin America Poliomyelitis Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Poliomyelitis Vaccines Revenue by Application (2017-2028)
9.3 Latin America Poliomyelitis Vaccines Market Size by Country
9.3.1 Latin America Poliomyelitis Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Poliomyelitis Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Poliomyelitis Vaccines Market Size by Type
10.1.1 Middle East and Africa Poliomyelitis Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Poliomyelitis Vaccines Market Size by Application
10.2.1 Middle East and Africa Poliomyelitis Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Poliomyelitis Vaccines Market Size by Country
10.3.1 Middle East and Africa Poliomyelitis Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Corporation Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 IMBCA Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bio-Med Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Poliomyelitis Vaccines Industry Chain Analysis
12.2 Poliomyelitis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Poliomyelitis Vaccines Production Mode & Process
12.4 Poliomyelitis Vaccines Sales and Marketing
12.4.1 Poliomyelitis Vaccines Sales Channels
12.4.2 Poliomyelitis Vaccines Distributors
12.5 Poliomyelitis Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Poliomyelitis Vaccines Industry Trends
13.2 Poliomyelitis Vaccines Market Drivers
13.3 Poliomyelitis Vaccines Market Challenges
13.4 Poliomyelitis Vaccines Market Restraints
14 Key Findings in The Global Poliomyelitis Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
